Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GSK
GSK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GSK News
Sino Biopharmaceutical Secures GSK Respiratory Drug Rights in China
1h ago
seekingalpha
Oncology Research Sees New Opportunities with DDR Inhibitors
Jun 24 2026
Globenewswire
Oncology Research Sees New Opportunities with DDR Inhibitors
Jun 24 2026
Newsfilter
Investigation Alerts for Multiple Company Acquisitions
Jun 22 2026
Globenewswire
First Oral Carbapenem Antibiotic Approved in the US
Jun 17 2026
Newsfilter
First Oral Carbapenem Antibiotic Approved in the US
Jun 17 2026
Globenewswire
First Oral Carbapenem Antibiotic Approved in the US
Jun 17 2026
Newsfilter
GSK and Spero's Utebzi Approved by FDA for UTIs
Jun 17 2026
seekingalpha
Gilead's HIV Prevention Drug Filing Accepted by FDA
Jun 17 2026
NASDAQ.COM
Biotech IPO Market Reopens Amid M&A Surge
Jun 16 2026
CNBC
Biotech Investors Become More Selective Amid Market Changes
Jun 16 2026
Newsfilter
Investigation Alerts for Multiple Mergers
Jun 15 2026
Globenewswire
Global Market Sentiment Affected by Energy Prices
Jun 14 2026
seekingalpha
Biotech Sector Sees Surge in FDA and Global Approvals
Jun 12 2026
NASDAQ.COM
GSK Receives Orphan Drug Designation for VEXAS Syndrome Treatment
Jun 12 2026
NASDAQ.COM
UK Tech Ecosystem Rebounds with New Growth
Jun 10 2026
CNBC
Show More News
